ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CRO Selects Datatrak eSource for $1,800,000 Contract

Datatrak eSource was selected after a rigorous evaluation process of various clinical trial software systems. A key factor in the selection was Datatrak's customizable and reliably proven EDC that seamlessly integrates with all other eClinical functions to be a true eSource solution for healthcare and life sciences. Datatrak's platform requires only one login to access the central dashboard that controls all aspects clinical trial data management such as EDC, RTSM, eTMF, CTMS, ePRO, eConsent, and Global Enterprise Manage of All Processes, Alerts, Workflows, Documents, Timelines, and more in an all-in-one end-to-end solution with the flexibility to customize to meet the requirements of any study protocol.

AUSTIN, TX / ACCESS Newswire / November 11, 2025 / Datatrak International (OTC:DTRK) announces a CRO is entering into a $1,800,000 contract for eSource that includes key clinical trial data management solutions such as EDC, RTSM, eTMF, CTMS, ePRO, eConsent, and Global Enterprise Management. Datatrak's platform is centered around the industry's first EDC system that expanded into an all-in-one end-to-end eClinical solution with other key functions. This will drive efficiency and enable better visibility across the organization and its data management needs for overall study success.

The Datatrak platform is powered by Fountayn and its full complement of data management services from study start-up to study closeout. Fountayn provides an experienced full-service team of clinical operations and data management professionals to help with trial design, project management, data management, custom coding, study plan documentation, validation and quality assurance, study support services, and help desk solutions specialists based in the United States, European Union, and Japan throughout the study lifecycle. Schedule a demo at sales@fountayn.com to see why clinical researcher professionals trust Datatrak for solutions through the entire clinical trial lifecycle.

About Datatrak
Datatrak is transforming healthcare and life sciences through technological innovations from providing the first EDC technology to offering the first true eSource solution that seamlessly integrates all aspects of clinical trial data management including EDC, RTSM, RBM, eTMF, CTMS, ePRO, eConsent, Endpoint Adjudication, Imaging Data, Safety, Inventory Management, and Enterprise Management of Automated Alerts, Workflows, Documents, Timelines, and Global Oversight. No other company has been innovating in healthcare and life sciences as long as Datatrak. For over thirty years clinical trial professionals have trusted Datatrak for reliable and secure technology solutions. Datatrak complies with the highest Quality Assurance standards that are 21 CFR Part 11, GDPR, GCP, HIPAA, and CDISC compliant that are fully validated by our experienced team of software quality engineers. Datatrak's cloud-based platform is trusted in 83 countries, 6 continents, for over 10,000 clinical trials. Datatrak is based in Austin, Texas and has team members and data hosting infrastructure in its key service regions of the United States, Europe, and Japan. For more information, visit www.datatrak.com or www.fountayn.com.

Contact:
sales@fountayn.com
Datatrak Powered by Fountayn

SOURCE: Datatrak International



View the original press release on ACCESS Newswire

Recent Quotes

View More
Symbol Price Change (%)
AMZN  210.14
+4.77 (2.32%)
AAPL  251.49
+3.50 (1.41%)
AMD  202.68
+1.35 (0.67%)
BAC  47.52
+0.36 (0.76%)
GOOG  299.02
+0.23 (0.08%)
META  604.06
+10.40 (1.75%)
MSFT  383.00
+1.13 (0.30%)
NVDA  175.64
+2.94 (1.70%)
ORCL  154.34
+4.66 (3.11%)
TSLA  380.85
+12.89 (3.50%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.